Home/Filings/4/0001209191-20-062960
4//SEC Filing

Kamal Mostafa 4

Accession 0001209191-20-062960

CIK 0000019411other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 4:45 PM ET

Size

4.8 KB

Accession

0001209191-20-062960

Insider Transaction Report

Form 4
Period: 2020-12-09
Kamal Mostafa
CEO, Magellan Rx Management
Transactions
  • Sale

    Ordinary Common Stock, $0.01 par value

    2020-12-09$79.69/sh2,793$222,5742,824 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a Rule 10b-5-1 Plan.

Issuer

MAGELLAN HEALTH INC

CIK 0000019411

Entity typeother

Related Parties

1
  • filerCIK 0001647234

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:45 PM ET
Size
4.8 KB